[헬스코리아뉴스] Novartis' 'GAVUS' has been found some side effects.
The Korea Food and Drug Administration(KFDA) announced on 23 December that GAVUS tab 50mg and GAVUS mat 50/850mg·50/1000mg(Vildagliptin)', drugs used to treat diabetes, may lead to the development of a urticaria in some people.
Urticaria, also known as Hives, are a kind of skin rash notable for dark red, raised, itchy bumps.
GAVUS will has to carry the KFDA’s safety warning.
저작권자 © 헬스코리아뉴스 무단전재 및 재배포 금지
